课题基金 / 基金详情

Targeting Eph receptors as anti-cancer therapy in malignant glioma.

Targeting Eph receptors as anti-cancer therapy in malignant glioma.
靶向 Eph 受体作为恶性神经胶质瘤的抗癌治疗。
批准号:
nhmrc : 552489
负责人:
Dr David Walker
金额:
$26.91万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2009
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2009-01-01 至 2011-12-31

项目摘要

项目成果

Dr David Walker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Malignant gliomas are the commonest form of brain cancer and are characterised by a high degree of morbidity and mortality. Present treatment involves surgery and adjuvant chemoradiotherapy but despite best care the outlook for patients with this disease is poor. The increasing understanding of the biology of glioma offers the prospect of improved therapies. This proposal seeks to investigate a therapy target in this disease in animal models of human malignant glioma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing sustainable Indigenous Health Worker led community oral health interventions.
  • 批准号:
    nhmrc : 571390
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $22.97万
  • 财政年份:
    2009
  • 负责人:
    Dr David Walker
  • 依托单位:
Radiotherapy vs chemotherapy for low-grade gliomas stratified for genetic 1p loss: efficacy and quality of life benefits
  • 批准号:
    nhmrc : 509094
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $27.36万
  • 财政年份:
    2008
  • 负责人:
    Dr David Walker
  • 依托单位:
Sediment capture and deposition processes in coastal lagoons
  • 批准号:
    LP0883453
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $5.85万
  • 财政年份:
    2008
  • 负责人:
    Dr David Walker
  • 依托单位:
Process evaluation of the training of Aboriginal health workers in rurual communities in basic oral health care
  • 批准号:
    nhmrc : 326239
  • 项目类别:
    NHMRC Postgraduate Scholarships
  • 资助金额:
    $9.74万
  • 财政年份:
    2005
  • 负责人:
    Dr David Walker
  • 依托单位:
国内基金
海外基金
Eph/Ephrin调控神经元活动促进胶质瘤进展的作用机制研究
Eph-Ephrin 信号通路通过调控 PVT→CeA 神经环路干预双相情感障碍共病睡眠障碍发生的机制研究
基于Eph/ephrin信号轴的ephrinB2高表达工程化细胞膜修饰支架介导大节段外周神经缺损修复及其材料生物学机制
孕期感染所致Eph-Ephrin通路异常介导突触发育缺陷增加精神分裂症风险的机制研究
  • 批准号:
    --
  • 项目类别:
    联合基金项目
  • 资助金额:
    49万元
  • 批准年份:
    2019
  • 负责人:
    李文强
  • 依托单位: